Lux Biosciences to Present at the Thomas Weisel Partners Health Care Conference

JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences, a privately held biotechnology company focused on the treatment of ophthalmic diseases, announced today that Ulrich Grau, Ph.D., the company’s president and chief executive officer, will present at the Thomas Weisel Partner’s Health Care Conference on Thursday September 10 at 2:05 pm Eastern. The conference is being held in Boston from September 9-11 at the Four Seasons Hotel. Dr. Grau will provide an overview of Lux Biosciences’ development programs and corporate objectives.